Onderzoeker
Arnaud Marchand
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen, Bio-informatica en computationele biologie
Affiliaties
- Medicinale Chemie (Rega Instituut) (Afdeling)
Lid
Vanaf1 okt 2000 → 30 sep 2002
Publicaties
1 - 10 van 21
- Inhibitors of the Integrase–Transportin-SR2 interaction block HIV nuclear import(2018)
Auteurs: Jonas Demeulemeester, Jolien Blokken, Stéphanie De Houwer, Lieve Dirix, Arnaud Marchand, Patrick Chaltin, Frauke Christ, Zeger Debyser
- Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa(2017)
Auteurs: Veerle Liebens, Valerie Defraine, Wouter Knapen, Toon Swings, Arnaud Marchand, Patrick Chaltin, Maarten Fauvart, Jan Michiels
- Discovery of a new Mycobacterium tuberculosis thymidylate synthase X inhibitor with a unique inhibition profile(2017)
Auteurs: Rania Abou El Asrar, Arnaud Marchand, Patrick Chaltin, Steven De Jonghe, Eveline Lescrinier
Pagina's: 69 - 78 - Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus(2016)
Auteurs: Joanna Zmurko, Suzanne Kaptein, Jef Rozenski, Bharat Gadakh, Patrick Chaltin, Arnaud Marchand, Johan Neyts, Arthur Van Aerschot
Pagina's: 158 - 168 - Identification of drugs that restore primary cilium expression in cancer cells(2016)
Auteurs: Ali Talebi, Arnaud Marchand, Jonas Dehairs, Sebastian Munck, Patrick Chaltin, Johan Swinnen
Pagina's: 9975 - 92 - Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release(2015)
Auteurs: Kathi Held, Katrien De Clercq, Arnaud Marchand, Patrick Chaltin, Thomas Voets, Joris Vriens
Pagina's: E1363 - E1372 - H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1(2014)
Auteurs: Aloys Tijsma, Hendrik Jan Thibaut, Armando De Palma, Mohamed Koukni, Arnaud Marchand, Patrick Chaltin, Johan Neyts, Pieter Leyssen
Pagina's: 1 - 9 - Identification and characterization of an anti-pseudomonal dichlorocarbazol derivative displaying anti-biofilm activity(2014)
Auteurs: Veerle Liebens, Evelien Gerits, Wouter Knapen, Toon Swings, Hans Steenackers, Stijn Robijns, Arnaud Marchand, Patrick Chaltin, Katrijn De Brucker, Karin Thevissen, et al.
Pagina's: 5404 - 5408 - LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014)(2014)
Auteurs: Jonas Demeulemeester, Patrick Chaltin, Arnaud Marchand, Marc De Maeyer, Zeger Debyser, Frauke Christ
Pagina's: 609 - 632 - Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms(2014)
Auteurs: Nicolas Delattin, Katrijn De Brucker, Katleen Vandamme, Arnaud Marchand, Patrick Chaltin, Bruno Cammue, Karin Thevissen
Pagina's: 1035 - 1044
Patenten
1 - 10 van 10
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Tetrahydroquinoline derivatives as inhibitors of the yap/taz-tead activation for treating cancer (Inventor)
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Heterocycle derivatives for treating trpm3 mediated disorders (Inventor)
- Viral replication inhibitors (Inventor)
- Aryl derivatives for treating trpm3 mediated disorders (Inventor)
- Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (Inventor)
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Substituted indole derivatives as dengue viral replication inhibitors (Inventor)